BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 26, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 1999

View Archived Issues

Oncolytics Biotech enters reovirus development agreement

Read More

Chiroscience announces discovery of novel bone gene

Read More

Company Profile: FGene

Read More

Phase II HCV trial of Maxamine Therapy initiated

Read More

Sepracor and UCB reach Zyrtec isomer licensing agreement

Read More

Company Profile: GenoPlex

Read More

Squalene synthase inhibitor BMS-184494 tested in humans; spotlight on squalene synthase inhibitors

Read More

Plant-based Novogen product increases HDL cholesterol

Read More

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

Read More

Sonata launched in Germany

Read More

Licensing opportunity from Cornell Research Foundation: antidiabetic fagopyritols

Read More

Journal alert: neostigmine is effective in the treatment of acute colonic pseudo-obstruction

Read More

Merck researchers discover nonpeptide GnRH antagonist series

Read More

DGI BioTechnologies and Novo Nordisk sign collaboration

Read More

Anti-MRSA trinems designed at Merck & Co.

Read More

Ketone-based hematopoietic agents developed at Toray

Read More

Warner-Lambert synthesizes antibacterial substituted quinazoline-2,4-diones

Read More

Novel growth factor from GDNF-neurturin family identified by Washington U. researchers

Read More

Academic investigators describe new agent for BNCT

Read More

Preclinical study indicates potential of OGT-918 in treating complicated metabolic disorders

Read More

New PDE4 inhibitors with reduced emetogenic potential in the Kyowa Hakko pipeline

Read More

Beta agonist KUL-1248, a novel agent for facilitating stone discharge and suppressing colic

Read More

Roche exercises call option to redeem outstanding Genentech shares; company to remain independent

Read More

Structural Bioinformatics and DuPont announce strategic alliance

Read More

U. of Alberta designs new bis-benzimidazole anticancer agents

Read More

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

Read More

Repligen acquires additional capital for secretin trials in autism

Read More

Kissei presents binding profile and functional characterization of alpha1-adrenoceptor antagonist

Read More

Relenza receives approval in the E.U. for treatment of influenza

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing